Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL
-
Letto da:
-
Di:
A proposito di questo titolo
Standardizing the phage therapy industry through processes like clinical trails is the way to go . One of the fundamental steps to broader use of phage therapy and successful therapy is producing phages following Good Manufacturing Practices (GMP) and JAFRAL is the leader in this field. In today's show we sit down with JAFRAL's founder and CEO Dr. Frenk Smrekar, a visionary who has been working on the development of GMP for bacteriophages throughout his whole career. Let's give a listen to his journey of founding the company and his observation and thought on the phage therapy field development through a GMP perspective.
Learning more about JAFRAL @https://jafral.com
A review paper on GMP in Phage Therapy by https://doi.org/10.3389/fmicb.2020.01161